Bristol-Myers Squibb Company BDR (BMYB34)

Featured here, the Balance Sheet for Bristol-Myers Squibb Company BDR, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).

319.91 -11.08 (-3.35%)

26/05 Closed BRL Disclaimer

BMYB34 Balance Sheet

Total Current Assets

Name	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Total Current Assets	27,086	27,273	26,796	30,186	30,121
Cash and Short Term Investments	9,269	9,253	9,027	13,266	15,196
Cash	-	-	-	-	-
Cash & Equivalents	8,995	9,123	7,734	10,750	12,369
Short Term Investments	274	130	1,293	2,516	2,827
Total Receivables, Net	13,405	13,937	13,240	12,540	11,103
Accounts Receivables - Trade, Net	10,559	10,390	10,059	9,473	8,921
Total Inventory	2,605	2,339	2,074	2,142	2,104
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	1,807	1,744	2,455	2,238	1,718
Total Assets	94,281	96,820	98,196	100,357	103,034
Property/Plant/Equipment, Total - Net	7,605	7,475	6,918	6,810	6,941
Property/Plant/Equipment, Total - Gross	11,847	11,639	11,057	10,835	11,109
Accumulated Depreciation, Total	-4,242	-4,164	-4,139	-4,025	-4,168
Goodwill, Net	21,162	21,149	21,112	20,446	20,500
Intangibles, Net	33,569	35,859	38,179	37,690	40,103
Long Term Investments	2,005	2,187	1,959	1,973	2,185
Note Receivable - Long Term	2,846	3,547	3,181	3,067	2,182
Other Long Term Assets, Total	1,052	1,037	1,356	1,343	1,447
Other Assets, Total	-6,917	-7,884	-5,542	-3,735	-2,717
Total Current Liabilities	19,085	21,890	18,930	20,915	22,821
Accounts Payable	3,040	2,595	2,882	2,944	-
Payable/Accrued	-	-	-	-	-
Accrued Expenses	8,418	10,238	9,839	8,761	8,148
Notes Payable/Short Term Debt	498	367	229	307	225
Current Port. of LT Debt/Capital Leases	2,425	4,033	2,070	4,813	7,468
Other Current liabilities, Total	4,550	4,212	4,197	4,152	4,036
Total Liabilities	62,395	65,702	65,462	67,696	71,389
Total Long Term Debt	35,092	35,159	37,028	37,116	37,450
Long Term Debt	35,092	35,159	37,028	37,116	37,450
Capital Lease Obligations	-	-	-	-	-
Deferred Income Tax	1,568	2,166	2,881	3,034	3,809
Minority Interest	62	57	63	61	65
Other Liabilities, Total	6,090	6,063	6,331	6,263	7,019
Total Equity	31,886	31,118	32,734	32,661	31,645
Redeemable Preferred Stock, Total	-	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-	-
Common Stock, Total	292	292	292	292	292
Additional Paid-In Capital	45,140	45,165	44,956	44,375	43,756
Retained Earnings (Accumulated Deficit)	26,568	25,503	24,675	24,217	23,948
Treasury Stock - Common	-38,808	-38,618	-36,411	-35,292	-35,187
ESOP Debt Guarantee	-	-	-	-	-
Unrealized Gain (Loss)	-	-	-	-	-
Other Equity, Total	-1,306	-1,224	-778	-931	-1,164
Total Liabilities & Shareholders' Equity	94,281	96,820	98,196	100,357	103,034
Total Common Shares Outstanding	2,098	2,124	2,135	2,129.06	-
Total Preferred Shares Outstanding	-	-	-	-	-

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.